Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose onabotulinumtoxinA 7-point intradermal axillary injections for primary axillary hyperhidrosis
TCTR20220112005Phase 2Completed
- Sponsor
- Walailak University
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in essential axillary hyperhidrosis, sponsored by Walailak University. Started Jan 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
essential axillary hyperhidrosis
Beyond the preview
Go deeper on TCTR20220112005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220112005.